New diabetes clinical trial: GLUcose Transport and REnalPROtection in Chronic Kidney Disease

Published on: August 21, 2023 at 11:00AM
Conditions:   Chronic Kidney Disease;   Diabetes Mellitus, Type 2;   Hypertension
Interventions:   Drug: Dapagliflozin 10mg Tab;   Drug: Placebo
Sponsors:   IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy;   AstraZeneca
Recruiting
https://ift.tt/trnSkZ0